e-Drug3D

454

cas 11000-17-2

CLASS

HORMONE
ANTIDIURETICS
OXYTOCICS
VASOCONSTRICTOR AGENTS
TREATMENT OF POSTOPERATIVE ABDOMINAL DISTENTION

ROUTE (list)

INJECTION INTRAVENOUS

PK parameters

t1/2 0.25 HOUR

TARGET VASOPRESSIN RECEPTOR

PDB
1JK4 (DES 1-6 BOVINE NEUROPHYSIN II)

Ligand code = - (link to the list of PDB complexes)

Download experimental 3D coordinates of - with added hydrogens

MW 1084.27
NB_atoms 75
XLogP -5.40
PSA 410.339
NB_HD 20
NB_HA 27
fsp3 0.48
Lipinski(0=no;1=yes) 0

FDA
NDA 003402 (pdf not found) INN (VASOPRESSIN TANNATE) PITRESSIN TANNATE (PARKE DAVIS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 204485 (label) INN (VASOPRESSIN) VASOSTRICT (PH HEALTH) APPROVAL= AP YEAR= 2014
NDA 212593 (label) INN (VASOPRESSIN) VASOPRESSIN (AM REGENT) APPROVAL= AP YEAR= 2020
NDA 211538 (pdf not found) INN (VASOPRESSIN) VASOPRESSIN (EAGLE PHARMS) APPROVAL= AP YEAR= 2021
NDA 211857 (pdf not found) INN (VASOPRESSIN) VASOPRESSIN (AMPHASTAR PHARMS INC) APPROVAL= AP YEAR= 2022
NDA 212944 (pdf not found) INN (VASOPRESSIN) VASOPRESSIN (AMNEAL) APPROVAL= AP YEAR= 2022
NDA 212945 (pdf not found) INN (VASOPRESSIN) VASOPRESSIN (AMNEAL EU LTD) APPROVAL= TA YEAR= 2022
NDA 214314 (pdf not found) INN (VASOPRESSIN) VASOPRESSIN (EUGIA PHARMA) APPROVAL= AP YEAR= 2022
NDA 213206 (pdf not found) INN (VASOPRESSIN) VASOPRESSIN (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2023
NDA 217569 (label) INN (VASOPRESSIN) VASOPRESSIN IN SODIUM CHLORIDE 0.9% (BAXTER HLTHCARE CORP) APPROVAL= AP YEAR= 2023
NDA 217987 (pdf not found) INN (VASOPRESSIN) VASOPRESSIN (CIPLA) APPROVAL= AP YEAR= 2023
NDA 213988 (pdf not found) INN (VASOPRESSIN) VASOPRESSIN (DR REDDYS) APPROVAL= AP YEAR= 2024
NDA 216963 (pdf not found) INN (VASOPRESSIN) VASOPRESSIN (GLAND) APPROVAL= AP YEAR= 2024
NDA 217766 (label) INN (VASOPRESSIN) VASOPRESSIN IN SODIUM CHLORIDE 0.9% (LONG GROVE PHARMS) APPROVAL= AP YEAR= 2024